Related Experiment Video
Updated: May 16, 2026
06:51
Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
Published on: December 9, 2022
TIE2 Interacts with Major Vault Protein and Modulates Angiogenic Function in Human Retinal Microvascular Endothelial
Yuhong Ye1, Ning Cui1, Da Long1
1Department of Ophthalmology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Current Eye Research
|May 14, 2026
Summary
TIE2 protein is crucial for human retinal microvascular endothelial cell (HRMEC) angiogenesis. The study found TIE2 interacts with MVP, regulating cell function via the PI3K/AKT pathway, offering a new therapeutic target for retinal vascular diseases.
Area of Science:
- Vascular Biology
- Endothelial Cell Function
- Molecular Mechanisms of Angiogenesis
Background:
- Human retinal microvascular endothelial cell (HRMEC) dysfunction is implicated in retinal vascular diseases.
- Understanding the role of TIE2 in HRMEC angiogenesis is critical for developing effective treatments.
Purpose of the Study:
- To elucidate the molecular role of TIE2 in HRMEC angiogenesis.
- To identify the intracellular regulatory mechanisms of TIE2 in HRMECs.
Main Methods:
- TIE2 knockdown in HRMECs using lentiviral shRNA.
- Assessment of cell proliferation, angiogenesis, and apoptosis.
- Transcriptome analysis via RNA sequencing.
- Validation of TIE2-MVP interaction using co-immunoprecipitation and immunofluorescence.
- Investigation of PI3K/AKT pathway involvement.
Main Results:
- TIE2 knockdown suppressed HRMEC proliferation and angiogenesis while increasing apoptosis.
- Transcriptomic analysis revealed TIE2 knockdown affected pathways related to ion channels and signaling.
- TIE2 was found to interact with Major Vault Protein (MVP), influencing angiogenesis.
- The TIE2-MVP axis modulates angiogenic responses via the PI3K/AKT signaling pathway.
Conclusions:
- TIE2 plays a significant role in regulating HRMEC angiogenic function.
- The TIE2-MVP interaction modulates angiogenic responses, partly through PI3K/AKT signaling.
- The TIE2-MVP axis represents a potential therapeutic target for retinal vascular diseases.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...